These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7988307)
1. Different change in lipoprotein(a) levels from lipid levels of other lipoproteins with improved glycemic control in patients with NIDDM. Kikuchi T; Onuma T; Shimura M; Tsutsui M; Boku A; Matsui J; Takebe K Diabetes Care; 1994 Sep; 17(9):1059-61. PubMed ID: 7988307 [TBL] [Abstract][Full Text] [Related]
2. Lack of change of lipoprotein(a) levels by the optimization of glycemic control with insulin therapy in NIDDM patients. Caixas A; Pérez A; Qrdóñez-Llanos J; Bonet R; Rigla M; Castellví A; Bayen L; de Leiva A Diabetes Care; 1997 Sep; 20(9):1459-61. PubMed ID: 9283797 [TBL] [Abstract][Full Text] [Related]
3. Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications. Nakata H; Horita K; Eto M Metabolism; 1993 Oct; 42(10):1323-6. PubMed ID: 8412745 [TBL] [Abstract][Full Text] [Related]
5. Comparison of different insulin regimens in elderly patients with NIDDM. Wolffenbuttel BH; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC Diabetes Care; 1996 Dec; 19(12):1326-32. PubMed ID: 8941458 [TBL] [Abstract][Full Text] [Related]
6. Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus. O'Brien T; Nguyen TT; Harrison JM; Bailey KR; Dyck PJ; Kottke BA Mayo Clin Proc; 1994 May; 69(5):430-5. PubMed ID: 8170193 [TBL] [Abstract][Full Text] [Related]
7. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control. Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858 [TBL] [Abstract][Full Text] [Related]
8. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study. Dailey GE; Mohideen P; Fiedorek FT Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634 [TBL] [Abstract][Full Text] [Related]
9. Plasma lipoprotein(a) levels are not influenced by glycemic control in type 1 diabetes. Pérez A; Carreras G; Caixàs A; Castellví A; Caballero A; Bonet R; Ordóñez-Llanos J; de Leiva A Diabetes Care; 1998 Sep; 21(9):1517-20. PubMed ID: 9727901 [TBL] [Abstract][Full Text] [Related]
10. Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes. Haffner SM; Tuttle KR; Rainwater DL Metabolism; 1992 Feb; 41(2):116-20. PubMed ID: 1531244 [TBL] [Abstract][Full Text] [Related]
11. Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control? Romano G; Patti L; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G; Rivellese AA Diabetes; 1997 Oct; 46(10):1601-6. PubMed ID: 9313756 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein (a) levels in African-Americans with NIDDM. Scheer WD; Boudreau DA; Cook CB Diabetes Care; 1996 Oct; 19(10):1129-34. PubMed ID: 8886562 [TBL] [Abstract][Full Text] [Related]
13. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins. Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) concentrations and non-insulin-dependent diabetes mellitus: relationship to glycaemic control and diabetic complications. Chico A; Pérez A; Caixàs A; Ordóñez J; Pou JM; de Leiva A Diabetes Res Clin Pract; 1996 Jul; 33(2):105-10. PubMed ID: 8879965 [TBL] [Abstract][Full Text] [Related]
15. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients. Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K Diabetologia; 1995 Dec; 38(12):1434-42. PubMed ID: 8786017 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. DeFronzo RA; Goodman AM N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902 [TBL] [Abstract][Full Text] [Related]
17. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients? Alagözlü H; Gültekin F; Candan F Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258 [TBL] [Abstract][Full Text] [Related]
18. The effect of rosiglitazone on serum lipoprotein(a) levels in Korean patients with type 2 diabetes mellitus. Ko SH; Song KH; Ahn YB; Yoo SJ; Son HS; Yoon KH; Cha BY; Lee KW; Son HY; Kang SK Metabolism; 2003 Jun; 52(6):731-4. PubMed ID: 12800099 [TBL] [Abstract][Full Text] [Related]
19. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Falko JM; Osei K Am J Med; 1985 Sep; 79(3B):92-101. PubMed ID: 3931467 [TBL] [Abstract][Full Text] [Related]
20. The effect on metabolic control of second-generation sulfonylurea drugs in patients with NIDDM after secondary failure to first-generation agents. Sami T; Kabadi UM; Moshiri S J Fam Pract; 1996 Oct; 43(4):370-4. PubMed ID: 8874372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]